- Home
- ARTL vs ATNF Comparison
ARTL vs ATNF Comparison
Compare ARTL & ATNF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARTL
- ATNF
- Stock Information
- Founded
- ARTL 2011
- ATNF 2016
- Country
- ARTL United States
- ATNF United States
- Employees
- ARTL N/A
- ATNF N/A
- Industry
- ARTL Biotechnology: Pharmaceutical Preparations
- ATNF Biotechnology: Pharmaceutical Preparations
- Sector
- ARTL Health Care
- ATNF Health Care
- Exchange
- ARTL Nasdaq
- ATNF Nasdaq
- Market Cap
- ARTL 3.3M
- ATNF 3.8M
- IPO Year
- ARTL N/A
- ATNF N/A
- Fundamental
- Price
- ARTL $1.02
- ATNF $1.09
- Analyst Decision
- ARTL
- ATNF
- Analyst Count
- ARTL 0
- ATNF 0
- Target Price
- ARTL N/A
- ATNF N/A
- AVG Volume (30 Days)
- ARTL 1.2M
- ATNF 231.9K
- Earning Date
- ARTL 05-16-2025
- ATNF 05-19-2025
- Dividend Yield
- ARTL N/A
- ATNF N/A
- EPS Growth
- ARTL N/A
- ATNF N/A
- EPS
- ARTL N/A
- ATNF N/A
- Revenue
- ARTL N/A
- ATNF N/A
- Revenue This Year
- ARTL N/A
- ATNF N/A
- Revenue Next Year
- ARTL N/A
- ATNF N/A
- P/E Ratio
- ARTL N/A
- ATNF N/A
- Revenue Growth
- ARTL N/A
- ATNF N/A
- 52 Week Low
- ARTL $0.82
- ATNF $0.66
- 52 Week High
- ARTL $1.59
- ATNF $17.75
- Technical
- Relative Strength Index (RSI)
- ARTL 52.13
- ATNF 54.81
- Support Level
- ARTL $0.99
- ATNF $1.02
- Resistance Level
- ARTL $1.05
- ATNF $1.47
- Average True Range (ATR)
- ARTL 0.07
- ATNF 0.15
- MACD
- ARTL 0.00
- ATNF 0.03
- Stochastic Oscillator
- ARTL 30.00
- ATNF 40.90
About ARTL Artelo Biosciences Inc.
Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.
About ATNF 180 Life Sciences Corp.
180 Life Sciences Corp was formed as a clinical-stage biotechnology company, focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation, and fibrosis by employing research, and, where appropriate, combination therapy. In addition, it has acquired certain source code and intellectual property relating to the back-end technology platform to operate an online blockchain casino, and moving forward, it plans to focus the majority of its operations on the creation of the online blockchain casino, while looking to monetize certain prior development-stage therapeutic product candidates for unmet medical needs. It has one reportable operating segment, iGaming.